Effects of ganglionic blocking agents on the neuromuscular junction.
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D002217:Carbachol / Q000494:pharmacology; D002645:Chickens; D005730:Ganglionic Blockers / Q000494:pharmacology*; D006584:Hexamethonium Compounds / Q000494:pharmacology; D066298:In Vitro Techniques; D009469:Neuromuscular Junction / Q000187:drug effects*; D009538:Nicotine / Q000494:pharmacology; D010879:Piperazines / Q000494:pharmacology; D011984:Sensory Receptor Cells; D009435:Synaptic Transmission / Q000187:drug effects; D013757:Tetraethylammonium Compounds / Q000494:pharmacology
D005730:Ganglionic Blockers; D006584:Hexamethonium Compounds; D010879:Piperazines; D013757:Tetraethylammonium Compounds; D009538:Nicotine; D002217:Carbachol; D000109:Acetylcholine